Catalyst Wire Dossier Catalyst Wire Dossier

cefepime-tazobactam

cefepime-tazobactam · Wockhardt
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for cefepime-tazobactam, covering 2023-07-17 to 2023-07-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) [Phase 3]

See pricing